Effects of testosterone gel on physical performance in critically ill patients
Official title: Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill: a Randomised Double Blind Clinical Trial
Run by University Hospital, Clermont-Ferrand · NCT05825092 · Data updated 2026-11-12
This study tests if giving testosterone gel to critically ill patients on a ventilator can help improve their muscle strength and recovery compared to a placebo.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 79 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 5 sites (Bordeaux and 4 other locations) |
| Status | Recruiting |
| Started | July 21, 2023 |
| Main results expected | September 1, 2025 |
| Study ends | April 1, 2027 |
| Registry record updated | October 2, 2023 |
| Trial ID | NCT05825092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are males and females over 18 years old who are critically ill and require invasive mechanical ventilation for an extended period.
✕Probably not a fit
Patients who are not critically ill or those who do not require mechanical ventilation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of early administration of testosterone gel on physical performance in critically ill patients who are expected to require invasive mechanical ventilation for more than 48 hours. The study aims to address the severe testosterone deficiency commonly observed in these patients, which may contribute to muscle loss and functional disability. By comparing the effects of testosterone gel to a placebo, the trial seeks to determine whether testosterone can improve muscle strength and recovery during critical illness. The approach involves monitoring physical performance and muscular mass as primary outcomes.
Why it matters
Potential benefit: If successful, this treatment could enhance muscle recovery and physical performance in critically ill patients, potentially improving their overall outcomes.
How similar studies have gone: While the specific approach of using testosterone gel in critically ill patients is novel, previous studies have indicated that addressing hormonal deficiencies can have positive effects on recovery in similar populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females aged over 18 years * Negative pregnancy test (b-HCG) in female patient of childbearing potential * Invasive mechanical ventilation expected to be required for more than 48 hours * Written informed consent obtained from the patient or his/her legal representative * Social security cover * Contraception * Female patient of childbearing potential (entering the study after a menstrual period and who has a negative pregnancy test), who agrees to use a highly effective method of contraception and an effective method of contraception by her male partner during treatment and for 7 months after the last treatment intake * Male patient with a female partner of childbearing potential who agrees to use a highly effective method of contraception and an effective method of contraception by his female partner during treatment and for 4 months after the last treatment intake OR who agrees to use an effective method of contraception and a highly effective method of contraception by his female partner during the study and for 4 months after the last treatment intake Exclusion Criteria: * History of prostate cancer * History of breast cancer * Prostate cancer suspected or confirmed * Breast cancer suspected or confirmed * PSA (prostatic specific antigen) ≥ 4 ng/ml * ICU length of stay \> 120 h before enrollment * Moribund * Pre-existing illness with a life expectancy of \<6 months * Recent intracranial or spinal cord injury (\< 1 month) * Recent haemorrhagic or ischemic stroke (\< 1 month) * Neuromuscular disease * Cardiac arrest in non-shockable rhythm * Preexistent cognitive impairment or language barrier * Inability to walk without assistance prior to acute ICU illness (use of a cane or walkers not excluded) * Documented allergy to testosterone * Age \> 80 years * Pregnancy * Breast feeding
Where it's running
-
Service d'Anesthésie et Réanimation Centre Jean-Perrin
Clermont-Ferrand, France Recruiting -
Service de Médecine Intensive et Réanimation (MIR), CHU Clermont-Ferrand
Clermont-Ferrand, France Recruiting -
Service de Médecine Intensive et de Réanimation CHD La Roche sur Yon
La Roche-sur-Yon, France Recruiting -
Service de Médecine Intensive et Réanimation CHU Nantes, Hôtel Dieux
Nantes, France Recruiting -
Service de Medecine Intensive et Réanimation CHU de Bordeaux Hopital Pellegrin
Bordeaux, France Not yet recruiting
Study contacts
- Principal investigator: Konstantinos BACHOUMAS, MD — Centre Hospitalier Departemental Vendee
- Study coordinator: Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +33473754963
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.